July 1, 2009 — High doses, gadolinium-based MRI contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at the Mayo Clinic Florida, Jacksonville, Fla.

Contrary to other research indicating NSF is caused by gadolinium-based contrast agents that are commonly used today during MR procedures, this new study, which is published in the June 2009 issue of the American Journal of Roentgenology, found contradicting evidence.

The study examined the records of 61 patients who had been given high doses — from two to 10 times the usual MRI dose. The patients were undergoing interventional procedures before there were any reports linking gadolinium to NSF. Just one of these patients, a 58-year-old diabetic man with end-stage kidney disease and significant blood vessel blockages, developed NSF.

The researchers concluded: “Although gadolinium exposure appears to be a necessary precondition for NSF, gadolinium-based contrast agents alone are not sufficient to cause the disorder, even in very high doses. Clinically relevant nephrotoxicity of gadolinium-based contrast agents was not found.”

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

MRIs During Pregnancy Are Safe, But Gadolinium Scans May Increase Risk to Fetus

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

 

For more information: www.ajronline.org

Related Content

News | Magnetic Resonance Imaging (MRI)

May 13, 2022 — Alzheimer’s disease is the most common form of dementia, one of the major causes of dependency and ...

Time May 13, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 10, 2022 — At the ISMRM 2022 conference, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction ...

Time May 10, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 9, 2022 — At the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare ...

Time May 09, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 9, 2022 — For some sports such as tennis, the wrist is frequently under stress, and an injury to the wrist can ...

Time May 09, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 9, 2022 — Royal Philips, a global leader in health technology, announced it has received FDA 510(k) clearance for ...

Time May 09, 2022
arrow
News | Radiology Imaging

May 5, 2022 — Significant imaging findings (cancer, infection, pseudoaneurysm, fracture, bowel perforation) can occur in ...

Time May 05, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 3, 2022 — More than 60 million magnetic resonance imaging (MRI) scans are performed worldwide each year, but imaging ...

Time May 04, 2022
arrow
News | Radiology Imaging

May 4, 2022 — Understanding the most recent mechanisms of ballistic trauma and injury patterns aids to guide ...

Time May 04, 2022
arrow
Feature | Contrast Media

The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...

Time May 03, 2022
arrow
Subscribe Now